Results 21 to 30 of about 216,038 (323)
Testosterone Replacement Therapy in Chronic Kidney Disease Patients
Nutrients, 2022 (Background) The aim of our study was to evaluate the efficacy and safety of testosterone replacement therapy (TRT) in men with chronic kidney disease and hypogonadism on conservative and hemodialysis treatment. (Methods) The studied population consisted
Ryszard Skiba +7 more
semanticscholar +1 more source
Testosterone Replacement Therapy: A Narrative Review with a Focus on New Oral Formulations
touchREVIEWS in Endocrinology, 2022 Male hypogonadism affects 10–30% of the male population and is often under-recognized and under-treated. Different replacement formulations exist, each with specific benefits and limitations.
Salma Bhat, A. Dobs
semanticscholar +1 more source
Journal of Medical Case Reports, 2021 Background Acute portal vein thrombosis is a rare medical event usually seen in liver disease, but it can also occur due to any inherited or acquired procoagulable state that triggers venous occlusion.
Monica Zanconato Campitruz +2 more
doaj +1 more source
Sex playing with the mind: effects of oestrogen and testosterone on moon and cognition [PDF]
Arquivos de Neuro-Psiquiatria, 1999 Women now spend more than 1/3 of their lives in a state of oestrogen deprivation as a result of increased life expectancy. A similar, but milder, hypogonadal state has been described for elderly men.
OSVALDO P. ALMEIDA
doaj +1 more source
A time-resolved fluorescence immunoassay for the measurement of testosterone in saliva: Monitoring of testosterone replacement therapy with testosterone buciclate [PDF]
, 1998 Monitoring of testosterone replacement therapy requires a reliable method for testosterone measurement. Determination of salivary testosterone, which reflects the hormone's biologically active plasma fraction, is a superior technique for this purpose ...
Bals-Pratsch M +13 more
core +1 more source
Testosterone treatment in the aging male: myth or reality?
Swiss Medical Weekly, 2012 The definition of late onset hypogonadism in the aging male is controversially debated, and according to the latest literature consists of at least three especially sexual symptoms such as loss of morning erection, low sexual desire and erectile ...
Nicole Nigro, Mirjam Christ-Crain
doaj +1 more source
Transdermal delivery of testosterone [PDF]
, 2015 Male hypogonadism has been treated with exogenous testosterone since the 1930s. The early transdermal patches of testosterone became available in the 1980s with gel and solution preparations following subsequent decades.
Hadgraft, J, Lane, ME
core +1 more source
F1000Research, 2019 Late-onset hypogonadism (LOH) is the term used to describe the decline in serum testosterone levels associated with increasing age in men above 40 years.
Tharu Tharakan +3 more
doaj +1 more source
Testosterone Replacement, Muscle Strength, and Physical Function [PDF]
The World Journal of Men's Health, 2018 Muscle strength and physical function decrease in older men, as do testosterone levels. Nonetheless, the effects of testosterone replacement therapy on muscle strength and physical function remain inconclusive and equivocal.
You-Seon Nam +3 more
doaj +1 more source
Alterations in Lipids and Adipocyte Hormones in Female-to-Male Transsexuals [PDF]
, 2010 Testosterone therapy in men and women results in decreased high-density lipoprotein cholesterol (HDL) and increased low-density lipoprotein cholesterol (LDL).
Basra, Sukhdeep S. +3 more
core +5 more sources